A Phase III Clinical Trial to Evaluate Long-Term Protective Efficacy of Recombinant Zoster Vaccine (CHO Cell)
A Phase III Clinical Trial to Evaluate Long-Term Protective Efficacy of Recombinant Zoster Vaccine (CHO Cell)
Active, not recruiting · NCT07293065 · Registry updated 2026-03-10Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Phase III Clinical Trial to Evaluate Long-Term Protective Efficacy of Recombinant Zoster Vaccine (CHO Cell) | DNA Virus Infections, Herpesviridae infectious disease, Infections, Varicella Zoster Virus Infection, herpes zoster, viral infectious disease | Active, not recruiting | Phase 3 | 2026-03-10 | NCT07293065 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| MAXVAX Biotechnology Limited Liability Company | 10 |
4 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Hebei Provincial Center for Disease Control and Prevention | Shijiazhuang | China | 3 |
| Henan Center for Diseases Control and Prevention | Zhengzhou | China | 3 |
| Hubei Provincial Center for Disease Control and Prevention | Wuhan | China | 2 |
| Yunnan Center For Disease Control and Prevention | Kunming | China | 2 |